Status:
COMPLETED
Uncontrolled Hypertension Management Among Jordanian Adults
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Hypertension
Physical Activity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study will evaluate a newly developed multimodal health intervention including dietary approach to stop hypertension (DASH) diet, exercise (Ex), and medication adherence (MA) using motivational i...
Detailed Description
This interventional study specifically aims to: 1. Develop a valid multimodal health intervention that includes DASH, exercise, and medication adherence using MI counselling (DASH-ExMAMI) for hyperte...
Eligibility Criteria
Inclusion
- Patient's age between ≥ 18 and 65 years old.
- Has had diagnosed with hypertension and has started his or her treatment plan.
- Has uncontrolled hypertension: The average systolic blood pressure reading that is equal to or higher than 130 mmHg and/or diastolic blood pressure that is equal to or higher than 90 mmHg for the last two patients' records available at the health center.
- Has no other comorbidities that contraindicate exercise or restrict DASH diet.
- Written medical authorization (documented in patient's medical record) by the attending primary healthcare physician approving the patient's participation.
Exclusion
- Pregnant and postpartum women
- Has severe hypertension (SBP≥ 200 or DBP ≥110). Resting SBP greater than 200mm Hg or DBP greater than 110mm Hg is a relative contraindication to exercise stress testing.
- Has history of cardio-pulmonary, renal, or musculoskeletal comorbidities that contraindicate exercise or DASH diet.
- This research will exclude all clients who are contraindicated to undergo treadmill tests with extra precautions: history of myocardial infarction within six months, angina, cardiac dysrhythmias, symptomatic aortic stenosis, and heart failure, pulmonary embolus, infarction or hypertension, myocarditis or pericarditis, or endocarditis, aortic dissection, history of renal impairment, brittle diabetes mellitus, bronchial asthma, musculoskeletal problems that might worsen by exercise, and mental health problems that interfere with the comprehension of the intervention and its related safety measures. Clients with a history of metabolic disorders and who follow a specific diet restriction will also be excluded such as celiac disease.
Key Trial Info
Start Date :
June 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 7 2024
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06156631
Start Date
June 7 2024
End Date
October 7 2024
Last Update
October 22 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Barha Health Center
Irbid, Jordan, 21191
2
Al Tattweer Al Hadhary Health Center
Irbid, Jordan, 21191
3
Al Zahrawi Health Center
Irbid, Jordan, 21191
4
Maruw Health Center
Irbid, Jordan, 21191